Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,570,000 | 21,355,000 | 9,066,000 | 6,208,000 | 3,130,000 |
| Depreciation Amortization | 1,567,000 | 6,269,000 | 4,695,000 | 3,129,000 | 1,555,000 |
| Income taxes - deferred | 294,000 | -2,410,000 | 241,000 | 320,000 | 38,000 |
| Accounts receivable | N/A | 259,000 | N/A | N/A | N/A |
| Other Working Capital | -2,715,000 | 1,334,000 | -3,616,000 | -3,844,000 | -2,217,000 |
| Other Operating Activity | -733,000 | -10,005,000 | -673,000 | -989,000 | -922,000 |
| Operating Cash Flow | $1,983,000 | $16,802,000 | $9,713,000 | $4,824,000 | $1,584,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,057,000 | -2,236,000 | 2,067,000 | 4,547,000 | 5,309,000 |
| PPE Investments | -386,000 | -1,956,000 | -1,256,000 | -806,000 | -358,000 |
| Net Acquisitions | N/A | -1,000,000 | -1,000,000 | -1,000,000 | -585,000 |
| Purchase Of Investment | -605,000 | -3,537,000 | -2,526,000 | -1,663,000 | N/A |
| Sale Of Investment | 576,000 | 3,579,000 | 2,403,000 | 1,538,000 | 844,000 |
| Purchase Sale Intangibles | -32,000 | -261,000 | -188,000 | -41,000 | N/A |
| Other Investing Activity | 25,000 | 410,000 | 331,000 | 414,000 | -442,000 |
| Investing Cash Flow | $9,667,000 | $-4,740,000 | $19,000 | $3,030,000 | $4,768,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 345,000 | 9,886,000 | 7,569,000 | 5,064,000 | 444,000 |
| Debt Issued | N/A | 5,274,000 | 5,273,000 | 5,273,000 | 5,273,000 |
| Debt Repayment | -355,000 | -6,154,000 | -4,474,000 | -4,473,000 | -1,253,000 |
| Common Stock Issued | 372,000 | 862,000 | 656,000 | 411,000 | 313,000 |
| Common Stock Repurchased | -6,063,000 | -5,000,000 | -5,000,000 | -5,000,000 | -5,000,000 |
| Dividend Paid | -2,032,000 | -7,659,000 | -5,750,000 | -3,855,000 | -1,945,000 |
| Other Financing Activity | -2,987,000 | -10,559,000 | -7,881,000 | -5,316,000 | -2,739,000 |
| Financing Cash Flow | $-10,720,000 | $-13,350,000 | $-9,607,000 | $-7,896,000 | $-4,907,000 |
| Exchange Rate Effect | 55,000 | 53,000 | 67,000 | 37,000 | 21,000 |
| Beginning Cash Position | 1,431,000 | 2,666,000 | 2,666,000 | 2,666,000 | 2,666,000 |
| End Cash Position | 2,416,000 | 1,431,000 | 2,858,000 | 2,661,000 | 4,131,000 |
| Net Cash Flow | $985,000 | $-1,235,000 | $193,000 | $-5,000 | $1,465,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,983,000 | 16,802,000 | 9,713,000 | 4,824,000 | 1,584,000 |
| Capital Expenditure | -386,000 | -1,956,000 | -1,256,000 | -806,000 | -358,000 |
| Free Cash Flow | 1,597,000 | 14,846,000 | 8,457,000 | 4,018,000 | 1,226,000 |